263 filings
Page 3 of 14
8-K
1t74uq0zauhr glnsus
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
t4z8ok58qsvwctepczb2
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
8-K
rzq7wmgc4
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
424B5
mujr77qwv1dpjh
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
76yk4
14 Sep 22
Other Events
7:05am
8-K
xpduco2ajlh
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
sy43wd53qt7 1rq
12 May 22
Departure of Directors or Certain Officers
4:10pm
8-K
ek8y7lp3
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
slato7nmkkg
11 Apr 22
Departure of Directors or Certain Officers
4:06pm
8-K
m0szit0oznqesiyn24v0
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
rhmsofok
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
7sika9qf996wwa6tzxod
14 Feb 22
Larimar Therapeutics Provides Update on CTI-1601 Clinical Program
12:00am
8-K
906h973vbmj1crfncfcy
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am